Organovo Holdings Inc. buy dimontalban
Start price
14.05.14
/
50%
€97.94
Target price
19.06.14
€180.00
Performance (%)
8.92%
End price
19.06.14
€106.68
Summary
This prediction ended on 19.06.14 with a price of €106.68. The BUY prediction by dimontalban finished with a performance of 8.92%. dimontalban has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Organovo Holdings Inc. | 12.229% | 12.229% | -61.155% | -92.405% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
According to dimontalban what are the pros and cons of Organovo Holdings Inc. for the foreseeable future?
Pros
Standard Investments for future growth
Good culture
Differentiated customer and product portfolio
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very capable Management
Innovative
Strong uniques
Sustainability is important
Top 10 in its market
Small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
Cons
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
High risks in the balance sheet
ROE lower than 10% per year
EBIT decline/stagnation expected
Decining EBIT margin than peer group
High challenges to pay loans and raise capital
Growths slower than the competition
high free float
High risks for its business
Comments by dimontalban for this prediction
In the thread Organovo Holdings Inc. diskutieren
Turnaround
Chartechnisch sollte sich eine Trendumkehr etabliert haben. Fundamental ist die Firma ohnehin Zukunft pur. Die Frage ist nur ob sie sich gegen die Großen behaupten kann.
(Vom Mitglied beendet)
Stopped prediction by dimontalban for Organovo Holdings Inc.
Organovo Holdings Inc.
Start price
Target price
Perf. (%)
€1.06
27.11.23
27.11.23
€4.00
27.11.24
27.11.24
-4.33%
09.12.23
09.12.23
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
negative Cash Flow expected